HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCER
Prostate cancer (PC) is one of the most actual problems of modern oncourology. Hormone therapy (HT) using medical castration is the main method of treatment of patients with metastatic PC. HT with usage of the new class of drugs that block the receptors for luteinizing hormone releasing hormone (LHR...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
QUASAR, LLC
2015-01-01
|
| Series: | Исследования и практика в медицине |
| Subjects: | |
| Online Access: | https://www.rpmj.ru/rpmj/article/view/20 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841524376011276288 |
|---|---|
| author | K. M. Nyushko A. A. Krasheninnikov M. P. Golovaschenko A. D. Kaprin |
| author_facet | K. M. Nyushko A. A. Krasheninnikov M. P. Golovaschenko A. D. Kaprin |
| author_sort | K. M. Nyushko |
| collection | DOAJ |
| description | Prostate cancer (PC) is one of the most actual problems of modern oncourology. Hormone therapy (HT) using medical castration is the main method of treatment of patients with metastatic PC. HT with usage of the new class of drugs that block the receptors for luteinizing hormone releasing hormone (LHRH) is a promising and effective method of castration therapy that has a number of significant advantages over the use of analogues LHRH. This article presents areview of studies that compared the effectiveness and side effects of HT using antagonists and analogues LHRH. |
| format | Article |
| id | doaj-art-b1730cb38f904f869cb851d3f52b653c |
| institution | Kabale University |
| issn | 2410-1893 |
| language | Russian |
| publishDate | 2015-01-01 |
| publisher | QUASAR, LLC |
| record_format | Article |
| series | Исследования и практика в медицине |
| spelling | doaj-art-b1730cb38f904f869cb851d3f52b653c2025-02-03T07:12:18ZrusQUASAR, LLCИсследования и практика в медицине2410-18932015-01-0111697310.17709/2409-2231-2014-1-1-69-7310HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCERK. M. Nyushko0A. A. Krasheninnikov1M. P. Golovaschenko2A. D. Kaprin3Moscow Oncology Institute of the Hertsen FMRC MH RF (Moscow, Russian Federation) 3, 2 B otkinskiy proezd, 125284, Russian Federation, MoscowMoscow Oncology Institute of the Hertsen FMRC MH RF (Moscow, Russian Federation) 3, 2 B otkinskiy proezd, 125284, Russian Federation, MoscowMoscow Oncology Institute of the Hertsen FMRC MH RF (Moscow, Russian Federation) 3, 2 B otkinskiy proezd, 125284, Russian Federation, MoscowHertsen FMRC MH RF (Obninsk, Russian Federation) 4, st. Korolev, 249036, Russian Federation, Kaluga region, ObninskProstate cancer (PC) is one of the most actual problems of modern oncourology. Hormone therapy (HT) using medical castration is the main method of treatment of patients with metastatic PC. HT with usage of the new class of drugs that block the receptors for luteinizing hormone releasing hormone (LHRH) is a promising and effective method of castration therapy that has a number of significant advantages over the use of analogues LHRH. This article presents areview of studies that compared the effectiveness and side effects of HT using antagonists and analogues LHRH.https://www.rpmj.ru/rpmj/article/view/20prostate canceranalogues and antagonists of luteinizing hormone releasing hormonethe castration refractorycardiovascular diseasecardiovascular risk. |
| spellingShingle | K. M. Nyushko A. A. Krasheninnikov M. P. Golovaschenko A. D. Kaprin HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCER Исследования и практика в медицине prostate cancer analogues and antagonists of luteinizing hormone releasing hormone the castration refractory cardiovascular disease cardiovascular risk. |
| title | HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCER |
| title_full | HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCER |
| title_fullStr | HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCER |
| title_full_unstemmed | HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCER |
| title_short | HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCER |
| title_sort | hormone therapy with usage of agonists and antagonists of luteinizing hormone releasing hormone in patients with prostate cancer |
| topic | prostate cancer analogues and antagonists of luteinizing hormone releasing hormone the castration refractory cardiovascular disease cardiovascular risk. |
| url | https://www.rpmj.ru/rpmj/article/view/20 |
| work_keys_str_mv | AT kmnyushko hormonetherapywithusageofagonistsandantagonistsofluteinizinghormonereleasinghormoneinpatientswithprostatecancer AT aakrasheninnikov hormonetherapywithusageofagonistsandantagonistsofluteinizinghormonereleasinghormoneinpatientswithprostatecancer AT mpgolovaschenko hormonetherapywithusageofagonistsandantagonistsofluteinizinghormonereleasinghormoneinpatientswithprostatecancer AT adkaprin hormonetherapywithusageofagonistsandantagonistsofluteinizinghormonereleasinghormoneinpatientswithprostatecancer |